Targetting PD-L1 with avelumab in metastatic Merkel cell carcinoma

Cochlear sparing via intensity modulated radiotherapy

Ten years of letrozole improves survival and quality of life in early-diagnosed breast cancer.

Daratumumab slows progression in refractory multiple myeloma

Developments in haematological malignancies

Early integrated palliative care to improve family caregivers outcomes

Recent developments in targeted therapies

First results of a prospective bendamustine/rituximab trial in patients with MCL

Performance characteristics and stage distribution of invasive epithelial ovarian/tubal/peritoneal cancers

MyPathway guidance of targeted therapy based on molecular profiles

Testing the safety and efficacy of the PD-L1 antibody durvalumab

Upfront autologous stem cell transplantation for newly diagnosed multiple myeloma